Drawing for RYNLEAP

USPTO serial 79445967

RYNLEAP

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
COLLIS, BRIAN J
Law office
TMO LAW OFFICE 129

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RYNLEAP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for treatment of cancer-related diseases and disorders.SECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 7, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 2, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2026DOCKASSIGNED TO EXAMINER—
Mar 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 19, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance